anti tumor activity
Recently Published Documents


TOTAL DOCUMENTS

2990
(FIVE YEARS 964)

H-INDEX

70
(FIVE YEARS 12)

2022 ◽  
Vol 12 (3) ◽  
pp. 630-633
Author(s):  
Chencheng Ding ◽  
Yunjie Zheng ◽  
Dan Li ◽  
Min Zhu ◽  
Yong Zhu

Hepatocellular carcinoma (HCC) seriously threatens human health and life quality. Natural killer (NK) cells play important roles in liver immune function. Bone marrow mesenchymal stem cell (BMSC) exosomes (Exo) participate in tissue damage. This study explored BMSC-Exo’s effect on NK cells’ anti-tumor activity. NK cells were isolated from the livers of mice with liver cancer. NK cells with or without BMSC-Exo treatment were co-cultured with liver cancer cells to assess cell proliferation. Administration of BMSC-Exo into mice with liver cancer significantly suppressed liver cancer cell growth. In addition, BMSC-Exo treatment significantly improved NK cells’ anti-tumor effect whic was related to BMSC-Exo-induced up-regulation of miR-1925. Implantation of BMSC-Exo into mice with liver cancer at different time periods can significantly suppress liver cancer cell growth. At the same time, BMSC-Exo implantation inhibited the expression of cell proliferation marker protein(Ki67). In vitro study found that BMSC-Exo treatment significantly increased miR-1925 level and the toxicity of NK cells to HCC cells. In addition, miR-1925 overexpression in NK cells significantly increased NK cells’ anti-tumor activity. In conclusion, this study proved that up-regulation of miR-1925 by BMSC can inhibit the growth of liver cancer by promoting the anti-tumor activity of NK cells.


2022 ◽  
Vol 74 ◽  
pp. 39-45
Author(s):  
Rigel J Kishton ◽  
Suman K Vodnala ◽  
Raul Vizcardo ◽  
Nicholas P Restifo

2022 ◽  
Author(s):  
Daisuke Kaida ◽  
Takayuki Satoh ◽  
Ken Ishida ◽  
Rei Yoshimoto

Pre-mRNA splicing is indispensable for eukaryotic gene expression. Splicing inhibition causes cell cycle arrest and cell death, which are the reasons of potent anti-tumor activity of splicing inhibitors. Here, we found that truncated proteins are involved in cell cycle arrest and cell death upon splicing inhibition. We analyzed pre-mRNAs accumulated in the cytoplasm where translation occurs, and found that a truncated form of the p27 CDK inhibitor, named p27*, is translated from pre-mRNA and accumulated in G2 arrested cells. Overexpression of p27* caused G2 phase arrest through inhibiting CDK-cyclin complexes. Conversely, knockout of p27* accelerated resumption of cell proliferation after washout of splicing inhibitor. Interestingly, p27* was resistant to proteasomal degradation. We propose that cells produce truncated proteins with different nature to the original proteins via pre-mRNA translation only under splicing deficient conditions to response to the splicing deficient conditions.


2022 ◽  
Author(s):  
Yifeng Zhan ◽  
Youyun Wang ◽  
Puzhao Wang ◽  
Hongda Zhu ◽  
Huiling Guo ◽  
...  

Abstract In this paper, a series of novel 5-fluorouracil-dithiocarbamate conjugates were designed, synthesized and evaluated in vitro . The results of cytotoxicity assays illuminated that these conjugates had anti-tumor activity against B16, Hela and U87MG, and compound P3 exhibited excellent growth inhibition against U87MG cells. Interestingly, the cytotoxicity of these conjugates was significantly increased when combined with copper ions. Meanwhile, colony-formation assays, transwell migration assays, cell apoptosis assays and cell cycle distribution assays were performed to explore the anti-tumor mechanism of conjugates. Compound P3 and P4 exhibited good biological activity in above four experiments when combined with copper ions. Especially, P3 displayed better bioactivity compared to the other three compounds. These results indicated that conjugates might be metabolized in the cells to produce dithiocarbamates, then metabolites formed complexes with copper ions, generating anti-tumor effects. Furthermore, conjugates and their metabolized dithiocarbamate derivatives were investigated by molecular docking, the results exhibited that P3 had the strongest interaction with the proteins 6CCY and 5T92, which was consistent with the obtained results of cell experiments. Compound P3 might be a potential lead-compound for the treatment of breast cancer and glioma. Further research in vivo about these compounds would be performed in our following work.


2022 ◽  
Author(s):  
Sha Zhou ◽  
Sen Lu ◽  
Chenchen Guo ◽  
Lei Wu ◽  
Zhanying Zheng ◽  
...  

This study prepared 25 sulfonylurea compounds to evaluate anti-tumor activity. Through experimental investigations in MDA-MB-231 and MCF-7, i.e., cell lines of breast carcinoma of human, we have concluded that some compounds can significantly suppress breast carcinoma cells from growing and proliferating. Moreover, the compound M’s inhibitory effect on cells of breast carcinoma is concentration-dependent under a certain treatment time; and the inhibitory effect of the compound M on breast carcinoma cells is time-dependent under a certain concentration. In addition, we also found that the compound M can effectively suppress cells of breast carcinoma from migration and independent survival. The results can show the prospect of research and development of new breast carcinoma treatment drug.


Author(s):  
BO LI ◽  
Jun Wu ◽  
Lei Tang ◽  
Xu Lian ◽  
Zhongwen Li ◽  
...  

Seventeen C20-O-alkyl/benzyl oximes derivatives were synthesized in concise and effective method. Most of these derivatives showed tens to several hundreds nanomolar IC50 values against HT-29 colorectal, HGC-27 gastric and MDA-MB-231...


Sign in / Sign up

Export Citation Format

Share Document